ArticleJournal of neuro-oncology2026
Intraoperative tract mapping through the biopsy cannula during stereotactic biopsy of brainstem lesions: a prospective feasibility study.
Article in Journal of neuro-oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Diagnostic yield, safety, and molecular-era clinical utility of stereotactic biopsy for brainstem lesions: a contemporary systematic review and meta-analysis.Frontiers in surgery · 2026Pooled it
- Comment on: "Intraoperative tract mapping through the biopsy cannula during stereotactic biopsy of brainstem lesions: a prospective feasibility study".Acta neurologica Belgica · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveStereotactic biopsy (STB) of brainstem lesions remains associated with neurological morbidity due to the dense eloquent tracts. Conventional intraoperative mapping cannot be directly applied in the stereotactic setting. We evaluated the feasibility, safety, and clinical relevance of intraoperative tract mapping through the inner cannula of the biopsy needle during brainstem STB.
methodsIn a prospective consecutive series, 16 patients underwent frame-based STB of intrinsic brainstem lesions. Mapping of corticospinal, corticonuclear, and medial lemniscus pathways was performed through a dual epidural D-wave electrode inserted into the biopsy cannula at the planned target depth. Sampling proceeded only at sites without tract responses; needle orientation was adjusted (first by rotation, then by depth correction) when responses were detected. Neurological status was assessed preoperatively and at discharge.
resultsTract responses were identified in 9 patients (56%). Corticospinal responses were recorded in 5 (31%), medial lemniscus responses in 6 (38%), and corticonuclear responses in 2 (12%). Mapping indicated proximity of the biopsy target to eloquent pathways in multiple cases, prompting needle orientation adjustments. Neurological worsening occurred in 4 patients (25%), including 2 severe deficits. The most severe deficit occurred in a medullary lesion where persistent corticobulbar responses indicated direct tract involvement. No permanent deterioration occurred in patients without tract responses and without CT-proven complications.
conclusionsIntraoperative tract mapping through the biopsy cannula during brainstem STB is feasible and compatible with awake procedures. Detecting tract proximity provides functional information at the sampling site and may reduce the risk of neurological injury.
Indexed as
Identifiers
42115539What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.